Registration process for modified new drugs to be simplified

The KFDA plans to simplify the registration process for a modified new drug in order to enhance the industrial competitiveness and to encourage the development of such modified new drugs, which include a new drug modified only with its salt, dosage form, composition and efficacy. The regulations pertaining to examine the application for the registration will be prepared and announced around the...